These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19932084)

  • 21. Interactions between the apolipoprotein a1/c3/a5 haplotypes and alcohol consumption on serum lipid levels.
    Yin RX; Li YY; Wu JZ; Pan SL; Liu CW; Lin WX; Yang DZ
    Alcohol Clin Exp Res; 2013 Feb; 37(2):234-43. PubMed ID: 22924697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
    Qi L; Liu S; Rifai N; Hunter D; Hu FB
    Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
    Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
    Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides.
    Dallongeville J; Cottel D; Wagner A; Ducimetière P; Ruidavets JB; Arveiler D; Bingham A; Ferrières J; Amouyel P; Meirhaeghe A
    BMC Med Genet; 2008 Sep; 9():84. PubMed ID: 18789138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
    Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
    Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.
    Talmud PJ; Cooper JA; Hattori H; Miller IP; Miller GJ; Humphries SE
    Diabetologia; 2006 Oct; 49(10):2337-40. PubMed ID: 16917759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.
    Novotny D; Vaverkova H; Karasek D; Malina P
    Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of associations between apolipoprotein A5 and C3 gene polymorphisms with plasma triglyceride and lipid levels.
    Taşkin E; Bağci H; Turan MK
    Rev Assoc Med Bras (1992); 2023; 69(3):415-420. PubMed ID: 36921196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
    Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
    Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
    Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
    Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population.
    Moreno-Luna R; Perez-Jimenez F; Marin C; Perez-Martinez P; Gomez P; Jimenez-Gomez Y; Delgado-Lista J; Moreno JA; Tanaka T; Ordovas JM; Lopez-Miranda J
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2280-5. PubMed ID: 17356049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
    Fiegenbaum M; de Andrade FM; Hutz MH
    Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.
    Henneman P; van der Sman-de Beer F; Moghaddam PH; Huijts P; Stalenhoef AF; Kastelein JJ; van Duijn CM; Havekes LM; Frants RR; van Dijk KW; Smelt AH
    Eur J Hum Genet; 2009 May; 17(5):620-8. PubMed ID: 19034316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.
    Chandak GR; Ward KJ; Yajnik CS; Pandit AN; Bavdekar A; Joglekar CV; Fall CH; Mohankrishna P; Wilkin TJ; Metcalf BS; Weedon MN; Frayling TM; Hattersley AT
    BMC Med Genet; 2006 Oct; 7():76. PubMed ID: 17032446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
    Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
    Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.
    Miller M; Rhyne J; Chen H; Beach V; Ericson R; Luthra K; Dwivedi M; Misra A
    Arch Med Res; 2007 May; 38(4):444-51. PubMed ID: 17416293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
    Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
    Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
    Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
    Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.